YNIMG Journal 2026 Journal Article
Age dependence of brain oxygen metabolism in adults assessed by 3D constrained quantitative BOLD MRI
- Kathryn M. Jaroszynski
- Sina Dindarian
- Hyunyeol Lee
- John A. Detre
- Felix W. Wehrli
Global and regional variations in cerebral oxygen metabolism are known to be associated with both healthy aging and the early stages of neurodegeneration. To quantify age effects, a recently developed 3D constrained qBOLD protocol was implemented to determine voxelwise OEF, integrated with ASL-derived CBF measurements to compute CMRO2. Thirty-four healthy adults (23–87 years) were examined to identify global and regional patterns of cerebral oxygen metabolism across younger (<35, n = 15) and older (>50, n = 19) adults. Whole-brain OEF was greater in older than in younger adults (40. 2 ± 5. 1 % vs 34. 5 ± 4. 6 %, P = 0. 002), whereas CBF was lower (39. 5 ± 10. 3 vs 48. 3 ± 8. 3 mL/100g/min, P = 0. 011), resulting in comparable CMRO2 (144. 0 ± 31. 8 vs 150. 7 ± 30. 0 µmol/100g/min, P = 0. 537). Across participants, OEF increased by 1. 5 % and CBF declined by 2. 1 % per decade. Regionally, OEF was greater in older adults within medial temporal lobe (MTL) (37. 4 ± 5. 9 % vs 32. 2 ± 5. 1 %), hippocampus (37. 2 ± 7. 0 % vs 29. 1 ± 6. 1 %), amygdala (38. 3 ± 8. 6 % vs 27. 9 ± 6. 1 %), thalamus (40. 5 ± 6. 4 % vs 32. 5 ± 7. 1 %), striatum (42. 7 ± 5. 3 % vs 36. 2 ± 5. 5 %), frontal (38. 7 ± 5. 2 % vs 34. 7 ± 5. 0 %), parietal (43. 9 ± 5. 1 % vs 38. 2 ± 5. 5 %), and occipital (40. 7 ± 6. 3 % vs 35. 1 ± 5. 3 %) lobes, all P < 0. 05. CMRO2 differed between older vs younger subjects only in the amygdala (126. 6 ± 35. 9 vs 97. 5 ± 31. 6 μmol/min/100 g, P = 0. 01). Exploring regional heterogeneity, MTL and its substructures exhibited reduced OEF relative to whole-brain averages in both groups. Overall findings indicate that cerebral oxygen metabolism remains largely preserved throughout adulthood. The combined qBOLD–ASL technique offers a robust framework for detecting regional variations in brain oxygen metabolism, characterizing both normative cerebrovascular aging and possibly early stages of neurodegeneration.